296 related articles for article (PubMed ID: 36070840)
1. Inflammasome activation in traumatic brain injury and Alzheimer's disease.
Johnson NH; de Rivero Vaccari JP; Bramlett HM; Keane RW; Dietrich WD
Transl Res; 2023 Apr; 254():1-12. PubMed ID: 36070840
[TBL] [Abstract][Full Text] [Related]
2. Genetic predisposition to Alzheimer's disease alters inflammasome activity after traumatic brain injury.
Johnson NH; Kerr NA; de Rivero Vaccari JP; Bramlett HM; Keane RW; Dietrich WD
Transl Res; 2023 Jul; 257():66-77. PubMed ID: 36758791
[TBL] [Abstract][Full Text] [Related]
3. The role of microglial inflammasome activation in pyroptotic cell death following penetrating traumatic brain injury.
Lee SW; de Rivero Vaccari JP; Truettner JS; Dietrich WD; Keane RW
J Neuroinflammation; 2019 Feb; 16(1):27. PubMed ID: 30736791
[TBL] [Abstract][Full Text] [Related]
4. HIF-1α aggravated traumatic brain injury by NLRP3 inflammasome-mediated pyroptosis and activation of microglia.
Yuan D; Guan S; Wang Z; Ni H; Ding D; Xu W; Li G
J Chem Neuroanat; 2021 Oct; 116():101994. PubMed ID: 34166779
[TBL] [Abstract][Full Text] [Related]
5. The pathological role of NLRs and AIM2 inflammasome-mediated pyroptosis in damaged blood-brain barrier after traumatic brain injury.
Ge X; Li W; Huang S; Yin Z; Xu X; Chen F; Kong X; Wang H; Zhang J; Lei P
Brain Res; 2018 Oct; 1697():10-20. PubMed ID: 29886252
[TBL] [Abstract][Full Text] [Related]
6. Sodium houttuyfonate attenuates neurological defects after traumatic brain injury in mice via inhibiting NLRP3 inflammasomes.
Yao X; Wang S; Chen Y; Sheng L; Li H; You H; Ye J; Zhang Q; Li J
J Biochem Mol Toxicol; 2021 Sep; 35(9):e22850. PubMed ID: 34405489
[TBL] [Abstract][Full Text] [Related]
7. Pyroptosis in Alzheimer's disease: cell type-specific activation in microglia, astrocytes and neurons.
Moonen S; Koper MJ; Van Schoor E; Schaeverbeke JM; Vandenberghe R; von Arnim CAF; Tousseyn T; De Strooper B; Thal DR
Acta Neuropathol; 2023 Feb; 145(2):175-195. PubMed ID: 36481964
[TBL] [Abstract][Full Text] [Related]
8. Altered Neuroinflammation and Behavior after Traumatic Brain Injury in a Mouse Model of Alzheimer's Disease.
Kokiko-Cochran O; Ransohoff L; Veenstra M; Lee S; Saber M; Sikora M; Teknipp R; Xu G; Bemiller S; Wilson G; Crish S; Bhaskar K; Lee YS; Ransohoff RM; Lamb BT
J Neurotrauma; 2016 Apr; 33(7):625-40. PubMed ID: 26414955
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of NLRP3 Inflammasome Activation: Its Role in the Treatment of Alzheimer's Disease.
Zhang Y; Zhao Y; Zhang J; Yang G
Neurochem Res; 2020 Nov; 45(11):2560-2572. PubMed ID: 32929691
[TBL] [Abstract][Full Text] [Related]
10. Cellular players that shape evolving pathology and neurodegeneration following traumatic brain injury.
Puntambekar SS; Saber M; Lamb BT; Kokiko-Cochran ON
Brain Behav Immun; 2018 Jul; 71():9-17. PubMed ID: 29601944
[TBL] [Abstract][Full Text] [Related]
11. Cognitive deficits develop 1month after diffuse brain injury and are exaggerated by microglia-associated reactivity to peripheral immune challenge.
Muccigrosso MM; Ford J; Benner B; Moussa D; Burnsides C; Fenn AM; Popovich PG; Lifshitz J; Walker FR; Eiferman DS; Godbout JP
Brain Behav Immun; 2016 May; 54():95-109. PubMed ID: 26774527
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of autophagy in microglia and macrophages exacerbates innate immune responses and worsens brain injury outcomes.
Hegdekar N; Sarkar C; Bustos S; Ritzel RM; Hanscom M; Ravishankar P; Philkana D; Wu J; Loane DJ; Lipinski MM
Autophagy; 2023 Jul; 19(7):2026-2044. PubMed ID: 36652438
[TBL] [Abstract][Full Text] [Related]
13. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ
CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390
[TBL] [Abstract][Full Text] [Related]
14. A Novel Inhibitor Targeting NLRP3 Inflammasome Reduces Neuropathology and Improves Cognitive Function in Alzheimer's Disease Transgenic Mice.
Kuwar R; Rolfe A; Di L; Blevins H; Xu Y; Sun X; Bloom GS; Zhang S; Sun D
J Alzheimers Dis; 2021; 82(4):1769-1783. PubMed ID: 34219728
[TBL] [Abstract][Full Text] [Related]
15. β-amyloid, microglia, and the inflammasome in Alzheimer's disease.
Gold M; El Khoury J
Semin Immunopathol; 2015 Nov; 37(6):607-11. PubMed ID: 26251237
[TBL] [Abstract][Full Text] [Related]
16. Omega-3 polyunsaturated fatty acid supplementation attenuates microglial-induced inflammation by inhibiting the HMGB1/TLR4/NF-κB pathway following experimental traumatic brain injury.
Chen X; Wu S; Chen C; Xie B; Fang Z; Hu W; Chen J; Fu H; He H
J Neuroinflammation; 2017 Jul; 14(1):143. PubMed ID: 28738820
[TBL] [Abstract][Full Text] [Related]
17. The immunology of traumatic brain injury: a prime target for Alzheimer's disease prevention.
Giunta B; Obregon D; Velisetty R; Sanberg PR; Borlongan CV; Tan J
J Neuroinflammation; 2012 Aug; 9():185. PubMed ID: 22849382
[TBL] [Abstract][Full Text] [Related]
18. Identification of inflammasome signaling proteins in neurons and microglia in early and intermediate stages of Alzheimer's disease.
Vontell RT; de Rivero Vaccari JP; Sun X; Gultekin SH; Bramlett HM; Dietrich WD; Keane RW
Brain Pathol; 2023 Jul; 33(4):e13142. PubMed ID: 36579934
[TBL] [Abstract][Full Text] [Related]
19. Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury.
Xu X; Yin D; Ren H; Gao W; Li F; Sun D; Wu Y; Zhou S; Lyu L; Yang M; Xiong J; Han L; Jiang R; Zhang J
Neurobiol Dis; 2018 Sep; 117():15-27. PubMed ID: 29859317
[TBL] [Abstract][Full Text] [Related]
20. The NLRP3 inflammasome in Alzheimer's disease.
Tan MS; Yu JT; Jiang T; Zhu XC; Tan L
Mol Neurobiol; 2013 Dec; 48(3):875-82. PubMed ID: 23686772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
